Alexander Peter Lin, Ph.D.
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Magnetic Resonance Spectroscopy | 37 | 2023 | 3760 | 2.920 |
Why?
|
| Brain Concussion | 13 | 2023 | 1320 | 1.410 |
Why?
|
| Glutamine | 5 | 2022 | 578 | 1.290 |
Why?
|
| Football | 12 | 2023 | 460 | 1.290 |
Why?
|
| Athletic Injuries | 8 | 2023 | 1154 | 1.250 |
Why?
|
| Glutamic Acid | 7 | 2022 | 1169 | 1.170 |
Why?
|
| Cystathionine | 1 | 2023 | 5 | 0.950 |
Why?
|
| Brain | 31 | 2023 | 26385 | 0.810 |
Why?
|
| Neurochemistry | 2 | 2020 | 29 | 0.780 |
Why?
|
| Aspartic Acid | 8 | 2022 | 576 | 0.660 |
Why?
|
| Athletes | 9 | 2022 | 1093 | 0.640 |
Why?
|
| Hypoxia-Ischemia, Brain | 1 | 2022 | 333 | 0.630 |
Why?
|
| Gait | 2 | 2020 | 793 | 0.630 |
Why?
|
| Phosphocreatine | 2 | 2015 | 269 | 0.570 |
Why?
|
| Magnetic Resonance Imaging | 29 | 2023 | 35421 | 0.540 |
Why?
|
| Nervous System Diseases | 4 | 2013 | 1622 | 0.530 |
Why?
|
| Brain Injuries | 7 | 2021 | 2025 | 0.520 |
Why?
|
| Fourier Analysis | 2 | 2015 | 447 | 0.510 |
Why?
|
| Tai Ji | 1 | 2018 | 285 | 0.490 |
Why?
|
| Heart Arrest | 2 | 2022 | 1470 | 0.480 |
Why?
|
| Muscle, Skeletal | 4 | 2018 | 4931 | 0.440 |
Why?
|
| Spinal Cord Injuries | 2 | 2019 | 931 | 0.430 |
Why?
|
| Sex Characteristics | 2 | 2020 | 2585 | 0.420 |
Why?
|
| Choline | 6 | 2023 | 493 | 0.420 |
Why?
|
| Soccer | 3 | 2021 | 133 | 0.420 |
Why?
|
| Phosphates | 1 | 2015 | 786 | 0.410 |
Why?
|
| Brain Chemistry | 7 | 2017 | 981 | 0.390 |
Why?
|
| Creatine | 4 | 2022 | 421 | 0.370 |
Why?
|
| Brain Neoplasms | 6 | 2022 | 8863 | 0.350 |
Why?
|
| Tomography, Emission-Computed | 1 | 2012 | 1144 | 0.340 |
Why?
|
| Algorithms | 7 | 2021 | 13881 | 0.330 |
Why?
|
| Hyperammonemia | 2 | 2020 | 76 | 0.310 |
Why?
|
| Carotid Artery, Common | 1 | 2008 | 183 | 0.300 |
Why?
|
| Molecular Imaging | 1 | 2014 | 828 | 0.280 |
Why?
|
| Diagnosis, Computer-Assisted | 2 | 2012 | 719 | 0.270 |
Why?
|
| Neurodegenerative Diseases | 4 | 2021 | 1061 | 0.240 |
Why?
|
| Spectrum Analysis | 2 | 2023 | 454 | 0.240 |
Why?
|
| Humans | 81 | 2023 | 744343 | 0.220 |
Why?
|
| Brain Mapping | 3 | 2021 | 6669 | 0.220 |
Why?
|
| Neurotransmitter Agents | 2 | 2003 | 647 | 0.210 |
Why?
|
| Sulfones | 2 | 2002 | 437 | 0.210 |
Why?
|
| Carbon Isotopes | 4 | 2010 | 467 | 0.210 |
Why?
|
| Brain Injury, Chronic | 2 | 2012 | 68 | 0.200 |
Why?
|
| Magnetic Resonance Imaging, Cine | 1 | 2008 | 964 | 0.200 |
Why?
|
| Cognitive Reserve | 1 | 2022 | 76 | 0.200 |
Why?
|
| Reproducibility of Results | 11 | 2021 | 19905 | 0.190 |
Why?
|
| Trigeminal Nerve | 1 | 2022 | 249 | 0.190 |
Why?
|
| Neurologic Examination | 3 | 2023 | 930 | 0.190 |
Why?
|
| Urea Cycle Disorders, Inborn | 1 | 2020 | 31 | 0.180 |
Why?
|
| Succinate-Semialdehyde Dehydrogenase | 1 | 2021 | 70 | 0.180 |
Why?
|
| Brain Diseases | 4 | 2018 | 1563 | 0.180 |
Why?
|
| Oxidative Stress | 2 | 2023 | 3086 | 0.180 |
Why?
|
| Organ Size | 3 | 2021 | 2252 | 0.170 |
Why?
|
| Sensitivity and Specificity | 8 | 2018 | 14722 | 0.160 |
Why?
|
| Nuclear Magnetic Resonance, Biomolecular | 1 | 2001 | 507 | 0.160 |
Why?
|
| Amino Acid Metabolism, Inborn Errors | 1 | 2021 | 255 | 0.160 |
Why?
|
| Betaine | 1 | 2018 | 87 | 0.160 |
Why?
|
| Diffusion Tensor Imaging | 5 | 2023 | 2305 | 0.150 |
Why?
|
| Neuropsychological Tests | 6 | 2022 | 6993 | 0.150 |
Why?
|
| Male | 37 | 2023 | 350118 | 0.150 |
Why?
|
| Hockey | 1 | 2017 | 90 | 0.150 |
Why?
|
| Sodium | 1 | 2022 | 1623 | 0.140 |
Why?
|
| Glutarates | 1 | 2018 | 236 | 0.140 |
Why?
|
| Echo-Planar Imaging | 1 | 2021 | 659 | 0.140 |
Why?
|
| Head Injuries, Closed | 1 | 2017 | 136 | 0.140 |
Why?
|
| Limbic System | 1 | 2019 | 426 | 0.140 |
Why?
|
| Middle Aged | 32 | 2023 | 213383 | 0.140 |
Why?
|
| Craniocerebral Trauma | 1 | 2021 | 482 | 0.140 |
Why?
|
| Gadolinium | 1 | 2001 | 952 | 0.140 |
Why?
|
| Phosphorus Isotopes | 1 | 2015 | 126 | 0.140 |
Why?
|
| Septum Pellucidum | 1 | 2015 | 58 | 0.130 |
Why?
|
| Energy Metabolism | 2 | 2018 | 2899 | 0.130 |
Why?
|
| Practice Guidelines as Topic | 1 | 2013 | 7279 | 0.130 |
Why?
|
| Corpus Callosum | 2 | 2021 | 737 | 0.130 |
Why?
|
| Protons | 4 | 2019 | 1127 | 0.130 |
Why?
|
| Anorexia Nervosa | 1 | 2023 | 1286 | 0.120 |
Why?
|
| Fucose | 1 | 2014 | 125 | 0.120 |
Why?
|
| Phantoms, Imaging | 1 | 2022 | 2480 | 0.120 |
Why?
|
| Alzheimer Disease | 4 | 2022 | 8037 | 0.120 |
Why?
|
| Evidence-Based Medicine | 1 | 2006 | 3610 | 0.120 |
Why?
|
| Adult | 27 | 2023 | 214055 | 0.120 |
Why?
|
| Amygdala | 2 | 2019 | 1315 | 0.120 |
Why?
|
| Thalamus | 2 | 2017 | 1023 | 0.110 |
Why?
|
| Receptors, Antigen, T-Cell | 1 | 2022 | 2540 | 0.110 |
Why?
|
| Hypothermia, Induced | 1 | 2018 | 752 | 0.110 |
Why?
|
| Coma | 1 | 2017 | 475 | 0.110 |
Why?
|
| Entropy | 1 | 2014 | 209 | 0.110 |
Why?
|
| Prediabetic State | 1 | 2018 | 499 | 0.110 |
Why?
|
| Young Adult | 10 | 2022 | 56430 | 0.110 |
Why?
|
| Cerebral Cortex | 2 | 2021 | 5708 | 0.110 |
Why?
|
| Carbohydrates | 1 | 2014 | 394 | 0.110 |
Why?
|
| Aged | 20 | 2023 | 163280 | 0.110 |
Why?
|
| Developmental Disabilities | 1 | 2021 | 1456 | 0.100 |
Why?
|
| Overweight | 1 | 2023 | 2371 | 0.100 |
Why?
|
| Insulin Resistance | 2 | 2023 | 3864 | 0.100 |
Why?
|
| Image Processing, Computer-Assisted | 6 | 2018 | 8949 | 0.100 |
Why?
|
| Nasal Cartilages | 1 | 2010 | 14 | 0.100 |
Why?
|
| Spinal Cord | 1 | 2019 | 1809 | 0.090 |
Why?
|
| Clinical Trials as Topic | 1 | 2006 | 7913 | 0.090 |
Why?
|
| Cattle | 1 | 2015 | 3922 | 0.090 |
Why?
|
| Tissue Distribution | 1 | 2014 | 2327 | 0.090 |
Why?
|
| Central Nervous System Diseases | 1 | 2014 | 518 | 0.090 |
Why?
|
| Propionates | 1 | 2010 | 169 | 0.090 |
Why?
|
| Female | 23 | 2023 | 380194 | 0.090 |
Why?
|
| Oxygen Consumption | 2 | 2007 | 1869 | 0.090 |
Why?
|
| Pilot Projects | 2 | 2018 | 8324 | 0.080 |
Why?
|
| Hippocampus | 2 | 2019 | 3675 | 0.080 |
Why?
|
| Nasal Obstruction | 1 | 2010 | 151 | 0.080 |
Why?
|
| Inositol | 2 | 2017 | 218 | 0.080 |
Why?
|
| Glutathione | 2 | 2023 | 589 | 0.080 |
Why?
|
| Prospective Studies | 6 | 2022 | 53288 | 0.070 |
Why?
|
| Chronic Disease | 3 | 2018 | 9146 | 0.070 |
Why?
|
| Rhinoplasty | 1 | 2010 | 226 | 0.070 |
Why?
|
| Occupational Diseases | 1 | 2015 | 1471 | 0.070 |
Why?
|
| Succinic Acid | 1 | 2007 | 83 | 0.070 |
Why?
|
| Decision Making | 3 | 2008 | 3887 | 0.070 |
Why?
|
| Military Personnel | 1 | 2015 | 1133 | 0.070 |
Why?
|
| Canavan Disease | 1 | 2006 | 5 | 0.070 |
Why?
|
| Adolescent | 7 | 2023 | 85781 | 0.060 |
Why?
|
| Age Factors | 2 | 2021 | 18370 | 0.060 |
Why?
|
| AIDS Dementia Complex | 1 | 2005 | 154 | 0.060 |
Why?
|
| Severity of Illness Index | 2 | 2020 | 15540 | 0.060 |
Why?
|
| Dimethyl Sulfoxide | 2 | 2002 | 249 | 0.060 |
Why?
|
| Nicotinamide Mononucleotide | 1 | 2023 | 17 | 0.060 |
Why?
|
| Whole Body Imaging | 1 | 2005 | 280 | 0.060 |
Why?
|
| Electroencephalography | 1 | 2018 | 6150 | 0.060 |
Why?
|
| Glioma | 1 | 2018 | 3401 | 0.060 |
Why?
|
| Neoplasm Recurrence, Local | 2 | 2018 | 9239 | 0.060 |
Why?
|
| Executive Function | 2 | 2022 | 1364 | 0.060 |
Why?
|
| Metabolism, Inborn Errors | 1 | 2005 | 288 | 0.050 |
Why?
|
| Prognosis | 2 | 2020 | 29063 | 0.050 |
Why?
|
| Depressive Disorder, Major | 1 | 2020 | 4644 | 0.050 |
Why?
|
| Lung | 1 | 2021 | 9856 | 0.050 |
Why?
|
| Veterans | 1 | 2015 | 2519 | 0.050 |
Why?
|
| Age of Onset | 2 | 2020 | 3271 | 0.050 |
Why?
|
| Time Factors | 6 | 2020 | 40075 | 0.050 |
Why?
|
| Physical Exertion | 1 | 2004 | 695 | 0.050 |
Why?
|
| Glucose | 2 | 2003 | 4397 | 0.050 |
Why?
|
| Neurocysticercosis | 1 | 2001 | 62 | 0.050 |
Why?
|
| Attention | 2 | 2022 | 2400 | 0.050 |
Why?
|
| Cardiac Pacing, Artificial | 1 | 2005 | 845 | 0.050 |
Why?
|
| Longitudinal Studies | 3 | 2021 | 13989 | 0.050 |
Why?
|
| Stress Disorders, Post-Traumatic | 1 | 2018 | 4266 | 0.050 |
Why?
|
| Obesity | 2 | 2023 | 12745 | 0.050 |
Why?
|
| Animals | 8 | 2015 | 168757 | 0.040 |
Why?
|
| L-Lactate Dehydrogenase | 1 | 2021 | 424 | 0.040 |
Why?
|
| Ammonia | 1 | 2020 | 239 | 0.040 |
Why?
|
| Physical Fitness | 1 | 2004 | 733 | 0.040 |
Why?
|
| NAD | 1 | 2023 | 593 | 0.040 |
Why?
|
| Occipital Lobe | 1 | 2021 | 379 | 0.040 |
Why?
|
| Gonadal Steroid Hormones | 1 | 2023 | 712 | 0.040 |
Why?
|
| Gyrus Cinguli | 2 | 2019 | 1091 | 0.040 |
Why?
|
| Memory | 2 | 2021 | 2174 | 0.040 |
Why?
|
| Image Interpretation, Computer-Assisted | 2 | 2017 | 3327 | 0.040 |
Why?
|
| Pacemaker, Artificial | 1 | 2005 | 816 | 0.040 |
Why?
|
| Muscle Contraction | 1 | 2004 | 1240 | 0.040 |
Why?
|
| Fetal Tissue Transplantation | 1 | 1999 | 139 | 0.040 |
Why?
|
| Autopsy | 1 | 2022 | 1020 | 0.040 |
Why?
|
| Kinetics | 2 | 2007 | 6473 | 0.040 |
Why?
|
| Urea | 1 | 2020 | 450 | 0.040 |
Why?
|
| Image Enhancement | 2 | 2007 | 2921 | 0.040 |
Why?
|
| Inflammation | 1 | 2018 | 10638 | 0.040 |
Why?
|
| Dietary Supplements | 2 | 2018 | 3297 | 0.040 |
Why?
|
| Death | 1 | 2022 | 678 | 0.040 |
Why?
|
| Prefrontal Cortex | 2 | 2023 | 2147 | 0.040 |
Why?
|
| Sodium Benzoate | 1 | 2017 | 15 | 0.040 |
Why?
|
| Phenylacetates | 1 | 2017 | 114 | 0.040 |
Why?
|
| Radionuclide Imaging | 1 | 2001 | 2031 | 0.040 |
Why?
|
| Neoplasms | 1 | 2006 | 21683 | 0.040 |
Why?
|
| Contrast Media | 3 | 2011 | 5300 | 0.040 |
Why?
|
| Synaptic Transmission | 1 | 2003 | 1178 | 0.040 |
Why?
|
| Imaging, Three-Dimensional | 2 | 2010 | 4042 | 0.030 |
Why?
|
| Oxygen | 2 | 2007 | 4189 | 0.030 |
Why?
|
| Parietal Lobe | 1 | 2021 | 838 | 0.030 |
Why?
|
| Task Performance and Analysis | 1 | 2020 | 780 | 0.030 |
Why?
|
| Estradiol | 1 | 2023 | 2020 | 0.030 |
Why?
|
| Glioblastoma | 1 | 2011 | 3481 | 0.030 |
Why?
|
| Glutamates | 1 | 2017 | 398 | 0.030 |
Why?
|
| Retirement | 1 | 2017 | 215 | 0.030 |
Why?
|
| Multicenter Studies as Topic | 1 | 2020 | 1677 | 0.030 |
Why?
|
| Pain | 1 | 2010 | 4986 | 0.030 |
Why?
|
| Frontal Lobe | 1 | 2021 | 1406 | 0.030 |
Why?
|
| Radiography, Thoracic | 1 | 2021 | 1265 | 0.030 |
Why?
|
| Memory Disorders | 1 | 2001 | 1184 | 0.030 |
Why?
|
| Cholesterol | 1 | 2023 | 2917 | 0.030 |
Why?
|
| Placebos | 1 | 2018 | 1676 | 0.030 |
Why?
|
| Administration, Oral | 1 | 2001 | 3913 | 0.030 |
Why?
|
| Body Height | 1 | 2020 | 1577 | 0.030 |
Why?
|
| Affect | 1 | 2021 | 1476 | 0.030 |
Why?
|
| Interpersonal Relations | 1 | 2021 | 1425 | 0.030 |
Why?
|
| Atrophy | 1 | 2017 | 1583 | 0.030 |
Why?
|
| Autistic Disorder | 1 | 2002 | 1185 | 0.030 |
Why?
|
| Psychomotor Performance | 1 | 2021 | 1901 | 0.030 |
Why?
|
| Isocitrate Dehydrogenase | 1 | 2018 | 871 | 0.030 |
Why?
|
| tau Proteins | 1 | 2022 | 1868 | 0.030 |
Why?
|
| Cohort Studies | 4 | 2021 | 40561 | 0.030 |
Why?
|
| Child | 5 | 2021 | 77709 | 0.030 |
Why?
|
| Body Weight | 1 | 2023 | 4669 | 0.030 |
Why?
|
| Huntington Disease | 1 | 1999 | 1124 | 0.030 |
Why?
|
| Aged, 80 and over | 2 | 2015 | 57776 | 0.030 |
Why?
|
| Anisotropy | 1 | 2015 | 1265 | 0.030 |
Why?
|
| Cognition Disorders | 2 | 2019 | 4043 | 0.020 |
Why?
|
| Linear Models | 1 | 2022 | 5952 | 0.020 |
Why?
|
| Diffusion Magnetic Resonance Imaging | 1 | 2023 | 2737 | 0.020 |
Why?
|
| Radiation Injuries | 1 | 1999 | 1180 | 0.020 |
Why?
|
| Amyloid beta-Peptides | 1 | 2023 | 3587 | 0.020 |
Why?
|
| ROC Curve | 1 | 2018 | 3527 | 0.020 |
Why?
|
| Oxidation-Reduction | 2 | 2007 | 2187 | 0.020 |
Why?
|
| Consensus | 1 | 2019 | 2959 | 0.020 |
Why?
|
| Recovery of Function | 1 | 2020 | 2925 | 0.020 |
Why?
|
| Case-Control Studies | 3 | 2017 | 21746 | 0.020 |
Why?
|
| Nasal Septum | 1 | 2010 | 127 | 0.020 |
Why?
|
| Body Water | 1 | 2010 | 343 | 0.020 |
Why?
|
| C-Reactive Protein | 1 | 2021 | 3778 | 0.020 |
Why?
|
| Reoperation | 1 | 1999 | 4201 | 0.020 |
Why?
|
| Gastric Bypass | 1 | 2017 | 812 | 0.020 |
Why?
|
| Evaluation Studies as Topic | 1 | 2010 | 1681 | 0.020 |
Why?
|
| Models, Chemical | 1 | 2010 | 626 | 0.020 |
Why?
|
| Seizures | 1 | 2020 | 2859 | 0.020 |
Why?
|
| Injections, Intravenous | 1 | 2010 | 1420 | 0.020 |
Why?
|
| Survival Analysis | 1 | 2020 | 10252 | 0.020 |
Why?
|
| Retrospective Studies | 3 | 2021 | 77449 | 0.020 |
Why?
|
| Schizophrenia | 1 | 2006 | 6882 | 0.020 |
Why?
|
| Rats | 3 | 2010 | 24260 | 0.020 |
Why?
|
| Biopsy | 1 | 1999 | 6756 | 0.020 |
Why?
|
| Positron-Emission Tomography | 1 | 2022 | 6234 | 0.020 |
Why?
|
| Mitochondria, Muscle | 1 | 2007 | 171 | 0.020 |
Why?
|
| Anxiety | 1 | 2021 | 4297 | 0.020 |
Why?
|
| Sex Factors | 1 | 2020 | 10397 | 0.020 |
Why?
|
| Proportional Hazards Models | 1 | 2020 | 12354 | 0.020 |
Why?
|
| Parkinson Disease | 1 | 1999 | 2775 | 0.020 |
Why?
|
| Breast Neoplasms | 1 | 2012 | 20822 | 0.020 |
Why?
|
| Phosphorus Radioisotopes | 1 | 2004 | 104 | 0.020 |
Why?
|
| Carbon Radioisotopes | 1 | 2005 | 577 | 0.020 |
Why?
|
| Double-Blind Method | 1 | 2018 | 12026 | 0.020 |
Why?
|
| Blood Glucose | 1 | 2018 | 6256 | 0.010 |
Why?
|
| Rats, Wistar | 1 | 2007 | 1901 | 0.010 |
Why?
|
| Predictive Value of Tests | 1 | 2018 | 15076 | 0.010 |
Why?
|
| Hydrogen-Ion Concentration | 1 | 2007 | 2557 | 0.010 |
Why?
|
| Leg | 1 | 2007 | 1116 | 0.010 |
Why?
|
| Follow-Up Studies | 2 | 2018 | 39050 | 0.010 |
Why?
|
| Molecular Structure | 1 | 2006 | 1899 | 0.010 |
Why?
|
| Pandemics | 1 | 2021 | 8388 | 0.010 |
Why?
|
| Data Interpretation, Statistical | 1 | 2010 | 2716 | 0.010 |
Why?
|
| Mitochondrial Diseases | 1 | 2003 | 320 | 0.010 |
Why?
|
| Myocardial Contraction | 1 | 2005 | 1585 | 0.010 |
Why?
|
| Staining and Labeling | 1 | 2003 | 1100 | 0.010 |
Why?
|
| Heart Conduction System | 1 | 2005 | 1047 | 0.010 |
Why?
|
| Child, Preschool | 2 | 2015 | 41006 | 0.010 |
Why?
|
| Tomography, X-Ray Computed | 1 | 2021 | 20129 | 0.010 |
Why?
|
| Feasibility Studies | 1 | 2007 | 5078 | 0.010 |
Why?
|
| Risk Factors | 1 | 2023 | 72290 | 0.010 |
Why?
|
| Exercise Test | 1 | 2004 | 2074 | 0.010 |
Why?
|
| Neoplasm Staging | 1 | 2011 | 11031 | 0.010 |
Why?
|
| Heart Rate | 1 | 2007 | 4091 | 0.010 |
Why?
|
| Treatment Outcome | 2 | 2017 | 63114 | 0.010 |
Why?
|
| Myocardial Ischemia | 1 | 2005 | 2148 | 0.010 |
Why?
|
| Motor Activity | 1 | 2004 | 2714 | 0.010 |
Why?
|
| Mutation | 1 | 2018 | 29786 | 0.010 |
Why?
|
| Life Style | 1 | 2004 | 3835 | 0.010 |
Why?
|
| Patient Satisfaction | 1 | 2005 | 3396 | 0.010 |
Why?
|
| Ventricular Function, Left | 1 | 2005 | 3670 | 0.010 |
Why?
|
| Neurons | 1 | 2003 | 9338 | 0.000 |
Why?
|
| Quality of Life | 1 | 2005 | 12804 | 0.000 |
Why?
|
| Heart Failure | 1 | 2005 | 10900 | 0.000 |
Why?
|